MedPath

The effects of Lacatobacillus on poly cystic onarian syndrom (PCOS)

Not Applicable
Conditions
poly cystic ovary syndrome (PCOS).
E28.2
Registration Number
IRCT2016081429362N1
Lead Sponsor
ational Nutrition and Food Sciences Institute Iran, Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
60
Inclusion Criteria

Target population sample of women with poly cystic ovary syndrome in women with poly cystic ovary syndrome referred to Ebne Sina hospital, Tehran, Iran.
age between 18 to 45 years ild; not using any kind of medication or supplements except Cyproterone acetate compound; no history of any chronic disease (diabetes, thyroid disease, autoimmune, cancer,..) during trial; not being professional athlete; no desire for following up an infertility treatment for the next months.
Exclusion criteria: smoking; pregnancy; lactation; tend to pregnancy for next three months; getting common cold or flu more than 5 days during trial; no desire for cooperation; making the major change in diet or physical activity during trial; using any immune-oppressive medication.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath